Utilities of the P-value Distribution Associated with Effect Size in Clinical Trials

Biometrical Journal

Volumn 45, Issue 6, 2003, Pages 659-669

  James Hung, H M ^a   O'Neill, Robert T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Confidence interval; Effect size; Interim analysis; Percentile; Power; significance level; Replication probability; Robustness

Indexed keywords

MEDICAL APPLICATIONS; ROBUSTNESS (CONTROL SYSTEMS);

CONFIDENCE INTERVAL; EFFECT SIZE; INTERIM ANALYSIS; P-VALUES; PERCENTILE; POWER; POWER;; REPLICATION PROBABILITY; ROBUSTNESS; SIGNIFICANCE LEVELS;

PROBABILITY DISTRIBUTIONS;

EID: 0141764704     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200390040     Document Type: Article

References (9)

1. HUNG, H. M. J., O'NEILL, R. T., BAUER, P., KÖHNE, K., 1997: The behavior of the P-value when the alternative hypothesis is true. Biometrics 53, 11-22.
2. SACKROWTTZ, H. and SAMUEL-CAHN. P., 1999: Values as random variables - expected P-values. The American Statistician 53, 326-331.
3. LEHMANN, E. L, 1993: The Fisher, Neyman-Pearson Theories of Testing hypotheses: one theory or two? Journal of the American Statistical Association 88, 1242-1249.
4. SCHERVISH, M. J., 1994: P-values: What they are and what they are not. The American Statistician 50, 203-206.
5. STERNE, J. A., 2002: Teaching hypothesis tests - time for significant change? Statistics in Medicine 21 , 985-994.
6. GOODMAN, S. N., 1999: Toward evidence-based medical statistics. 1. The P-value fallacy. Annuals of Internal Medicine 130, 995-1004.
7. SENN, S., 2002: Letter to the Editor: a comment on replication, p-values and evidence. Statistics in Medicine 21, 2437-2444.
8. GOODMAN, S. N., 1992: A comment on replication, P-values and evidence. Statistics in Medicine 11, 875-879.
9. LAN, K. K. G. and DEMETS, D. L., 1983: Discrete sequential boundaries for clinical trials. Biometrika 70, 659-663.